A first group of healthy adults has been dosed in a Phase 1 safety and tolerability trial of Lucid-21-302, a potential myelin-protective oral treatment for multiple sclerosis (MS), regardless of ...
Higher blood levels of bile acids — molecules found in the digestive fluid bile, which helps absorb fat in the gut — are associated with a slower progression of multiple sclerosis (MS), as ...
A clinical trial is evaluating whether combining a cognitive rehabilitation program with a virtual reality (VR)-based aerobic exercise regimen will improve learning and memory in people with ...